Belviq Weight Loss Drug Arrives in Pharmacies After Receiving FDA Approval Last Year

Posted on June 11, 2013

A weight loss drug named Belviq (lorcaserin) is arriving on the market after being approved by the FDA last year. It is the first new weight loss drug on the market in over ten years.

The drug reportedly produces only minor results. The L.A. Times reports that a study found people lost an average of 3% to 3.7% of their total body weight during a year on average. A list of possible side effects can be found on drugs.com. Some of the side effects can be neurological because the drug stimulates serotonin receptors in the brain to make you feel fuller.

CBS News medical contributor Dr. Holly Phillips says headache, dizziness, fatigue and nausea are some of the more common possible side effects. Take a look:

More from Science Space & Robots

  • Boston Dynamics Teases New Electric Atlas Humanoid Robot


  • Researchers Observe Many New Species on Seamounts Off Chile Coast


  • CSU Researchers Forecast Extremely Active Atlantic Hurricane Season


  • Hyundai Motor and Kia Unveil DAL-e Delivery Robot


  • H5N1 Discovered at Texas Egg Facility


    • Latest Tech Products

  • Apple Mac Mini with M4 Chip

  • Apple iPad Mini A17 Pro